Table 5.
Numbers of parent-reported adverse events during week 1
| Placebo group (n=170) | Oral steroid group (n=179) | ||
|---|---|---|---|
| No problems reported | 148 (87%) | 154 (86%) | |
| Children reported with at least one problem | 22 (13%) | 25 (14%) | |
| Total number of problems | 24 | 27 | |
| Respiratory tract infection | |||
| Phlegmy cough, cold, sneezing, temperature, nosebleed, conjunctivitis, itchy eyes, or generally unwell | 2 | 7 | |
| Headache | 3 | 4 | |
| Parotitis | 1 | 0 | |
| Ear pain on touch or earache | 1 | 1 | |
| Rash, pox, or scarlet fever | 2 | 0 | |
| Flushed cheeks | 0 | 1 | |
| Digestion | |||
| Increased appetite | 4 | 3 | |
| Low appetite | 2 | 0 | |
| Diarrhoea | 2 | 2 | |
| Constipation | 1 | 1 | |
| Nausea | 0 | 1 | |
| Behaviour | |||
| Hyperactive | 1 | 3 | |
| Tired | 1 | 1 | |
| Frustration | 1 | 0 | |
| Change in behaviour | 0 | 2 | |
| Parent states child not hearing | 1 | 0 | |
| Sleep walking | 0 | 1 | |
| Other | |||
| Finger infection | 1 | 0 | |
| Knee pain | 1 | 0 | |